骨髓基质通过诱导癌蛋白MUC1保护骨髓瘤细胞免受细胞毒性损伤
本研究探讨骨髓基质细胞对多发性骨髓瘤(MM)细胞耐药的影响机制,发现MM细胞与基质细胞共培养后对烷化剂和硼替佐米诱导的细胞死亡抵抗增强,且肿瘤细胞MUC1表达升高;该效应不依赖细胞接触,由白细胞介素-6及JAK-STAT通路介导,沉默MUC1可部分逆转基质介导的耐药。
要点
- MM细胞与基质细胞共培养后对烷化剂和硼替佐米的细胞死亡抵抗增强。
- 共培养使MM细胞MUC1表达升高,该效应不依赖细胞接触。
- MUC1表达由白细胞介素-6及JAK-STAT通路介导,沉默MUC1可部分逆转基质介导的耐药。
核心结论
- 骨髓基质细胞通过白细胞介素-6及JAK-STAT通路上调MM细胞MUC1表达,从而部分介导对细胞毒性及生物制剂的耐药。
- 沉默MM细胞MUC1可部分逆转基质细胞共培养所赋予的肿瘤耐药。
研究设计与样本
- 体外研究:将MM细胞与基质细胞共培养,检测其对细胞毒性及生物制剂的敏感性及MUC1表达变化。
主要发现
- MM细胞与基质细胞共培养后,暴露于烷化剂和蛋白酶体抑制剂硼替佐米时细胞死亡率下降。
- 共培养使MM细胞MUC1表达升高,且该效应不依赖细胞接触。
- MUC1表达由白细胞介素-6及后续JAK-STAT通路上调所介导。
- 沉默MM细胞MUC1可部分逆转基质细胞共培养对肿瘤耐药的影响。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Multiple myeloma (MM) is a lethal haematological malignancy that arises in the context of a tumour microenvironment that promotes resistance to apoptosis and immune escape. In the present study, we demonstrate that co-culture of MM cells with stromal cells results in increased resistance to cytotoxic and biological agents as manifested by decreased rates of cell death following exposure to alkylating agents and the proteosome inhibitor, bortezomib. To identify the mechanism of increased resistance, we examined the effect of the co-culture of MM cells with stroma cells, on expression of the MUC1 oncogene, known to confer tumour cells with resistance to apoptosis and necrosis. Co-culture of stroma with MM cells resulted in increased MUC1 expression by tumour cells. The effect of stromal cell co-culture on MUC1 expression was not dependent on cell contact and was therefore thought to be due to soluble factors secreted by the stromal cells into the microenvironment. We demonstrated that MUC1 expression was mediated by interleukin-6 and subsequent up-regulation of the JAK-STAT pathway. Interestingly, the effect of stromal cell co-culture on tumour resistance was partially reversed by silencing of MUC1 in MM cells, consistent with the potential role of MUC1 in mediating resistance to cytotoxic-based therapies.
引用
- Bar-Natan M, Stroopinsky D, Luptakova K, et al. Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1. Br J Haematol. 2017. PMID: 28107546. doi:10.1111/bjh.14493
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。